TY - JOUR
T1 - Microtubule inhibition as a proposed mechanism for the anthelmintic effect of phytochemicals isolated from Cicerbita alpina
AU - Horgan, Mark James
AU - Sigg, Ines
AU - Poulopoulou, Ioanna
AU - Rodriguez-Mejias, Francisco J
AU - Albertini, Eva
AU - Fusani, Pietro
AU - Fischer, Florian
AU - Martinidou, Eftychia
AU - Schuster, Daniela
AU - Martens, Stefan
AU - Dürr, Pidder Jansen
AU - Gauly, Matthias
AU - Stuppner, Hermann
AU - Weiss, Alexander
AU - Temml, Veronika
AU - Siewert, Bianka
N1 - Fischer, Schuster, Temml: Institute of Pharmacy,
Department of Pharmaceutical and Medicinal Chemistry and Research and Innovation Center for Novel Therapies
and Regenerative Medicine, Paracelsus Medical University Salzburg, Strubergasse 21, 5020 Salzburg, Austria
PY - 2025/2/3
Y1 - 2025/2/3
N2 - The alpine plant Cicerbita alpina (L.) Wallr., when grown as a sprout, is known as a bitter-tasting culinary delicacy. Recently it has also been reported to have anthelmintic activity, prompting further investigation into its mechanism of action. Liquid-liquid fractions were prepared from a methanolic extract of the aerial parts and were submitted in parallel to embryo development (ED), worm motility (WMT), and cytotoxicity assays for anthelmintic and toxicity evaluations. The anthelminthic assays revealed the more polar fractions to be most active against Ascaridia galli embryos (BuOH | 68% ED | c = 500 µg/ml and EtOAc | 65% ED | c = 500 µg/ml) and Caenorhabditis elegans adult worms (BuOH | 49% WMT | c = 150 µg/ml and EtOAc | 74% WMT | c = 150 µg/ml) suggesting the fraction's constituents possess dual anthelmintic activity against multiple life-cycle stages (i.e., eggs, worms) of helminths. Additionally, the BuOH fraction was non-cytotoxic to human cell-lines. Subsequent FCC and SEC derived subfractions were submitted to the anthelmintic assay workflow and the enriched subfractions B1 and E3.8, phytochemically assigned as 11-β,13-dihydrolactucin and luteolin, demonstrated bioactivity against the embryo phenotype (B1 | 58% ED | c = 1.8 µM and E3.8 | 46% ED | c = 1.7 µM) within range of the flubendazole control. Furthermore, luteolin was found to inhibit C. elegans egg hatching (luteolin | 65% EH | c = 10 µM | t = 10 h) within the range of the control albendazole. Both identified anthelmintic phytochemicals were found to affect tubulin polymerisation at a concentration of c = 50 µM. Together with in silico virtual screening studies, these results suggest microtubule stabilisation as a possible anthelmintic target and mechanism of action. This work effectively advocates the consideration of C. alpina extracts and fractions for the development of herbal therapeutics against parasitic helminths.
AB - The alpine plant Cicerbita alpina (L.) Wallr., when grown as a sprout, is known as a bitter-tasting culinary delicacy. Recently it has also been reported to have anthelmintic activity, prompting further investigation into its mechanism of action. Liquid-liquid fractions were prepared from a methanolic extract of the aerial parts and were submitted in parallel to embryo development (ED), worm motility (WMT), and cytotoxicity assays for anthelmintic and toxicity evaluations. The anthelminthic assays revealed the more polar fractions to be most active against Ascaridia galli embryos (BuOH | 68% ED | c = 500 µg/ml and EtOAc | 65% ED | c = 500 µg/ml) and Caenorhabditis elegans adult worms (BuOH | 49% WMT | c = 150 µg/ml and EtOAc | 74% WMT | c = 150 µg/ml) suggesting the fraction's constituents possess dual anthelmintic activity against multiple life-cycle stages (i.e., eggs, worms) of helminths. Additionally, the BuOH fraction was non-cytotoxic to human cell-lines. Subsequent FCC and SEC derived subfractions were submitted to the anthelmintic assay workflow and the enriched subfractions B1 and E3.8, phytochemically assigned as 11-β,13-dihydrolactucin and luteolin, demonstrated bioactivity against the embryo phenotype (B1 | 58% ED | c = 1.8 µM and E3.8 | 46% ED | c = 1.7 µM) within range of the flubendazole control. Furthermore, luteolin was found to inhibit C. elegans egg hatching (luteolin | 65% EH | c = 10 µM | t = 10 h) within the range of the control albendazole. Both identified anthelmintic phytochemicals were found to affect tubulin polymerisation at a concentration of c = 50 µM. Together with in silico virtual screening studies, these results suggest microtubule stabilisation as a possible anthelmintic target and mechanism of action. This work effectively advocates the consideration of C. alpina extracts and fractions for the development of herbal therapeutics against parasitic helminths.
KW - Animals
KW - Anthelmintics/pharmacology
KW - Caenorhabditis elegans/drug effects
KW - Plant Extracts/pharmacology
KW - Phytochemicals/pharmacology
KW - Microtubules/drug effects
KW - Humans
KW - Brassicaceae/chemistry
KW - Impact
KW - Acid
KW - L.
KW - Chicory cichorium-intybus
KW - Polymerization
KW - Helminth infections
KW - Tubulin binding
KW - Eggs
KW - Sesquiterpene lactones
KW - Caenorhabditis-elegans
U2 - 10.1038/s41598-024-73958-9
DO - 10.1038/s41598-024-73958-9
M3 - Original Article
C2 - 39900941
SN - 2045-2322
VL - 15
SP - 4108
JO - Scientific reports
JF - Scientific reports
IS - 1
M1 - 4108
ER -